Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Post by WinterCon Sep 11, 2016 11:21pm
272 Views
Post# 25227051

Chill... Respect opinions...What will happen Monday morning?

Chill... Respect opinions...What will happen Monday morning?Everyone needs to chill. None of you guys are wrong, it is over valued. This is a fact and they need to be making an ebitda of 7 million to be even considered a market cap of 200 million or damn high revenues and that is still being generous. Since this space is new and future prospects are so damn amazing, investors are willing to justify a 230 million price on this company at a mere ebitda of 1 million. Whether it goes down to 2.40 or 2.50 nobody can predict. Stocks don't increase in a straight line, it will dip sometimes. If you are looking to enter, you can wait for that opputunity. Months from now, it will be worth $4-5, so don't fuss too much guys.

You guys should be worried about how the MJ stocks will perform on Monday morning. All asset stocks, and banks are getting wrecked right now, globally. Brexit didn't influence MJ stocks much, but US stocks affects all US companies. Our economies are so tied, 40% of the Canadian export goes to the US (not sure about the exact figure). In turn, it will affect Canadian companies and trickle down to the buying power of everyday Canadians. Less buying power means lack of patient growth. Remember Medical MJ is not covered by national health care. 

Lack of investors means LP's looking to get funds are hurt, higher cost to burrow money, current COMA investors not being able to meet their demands are buying from smaller LP's in the meantime. This stock is run on future prospects and if that is hurt, it will affect MJ stocks for sure.

Something to think about. I have a job like everyone else and I will be watching the market carefully.
Bullboard Posts